329 related articles for article (PubMed ID: 29047342)
1. Effectiveness and patient safety of platelet aggregation inhibitors in the prevention of cardiovascular disease and ischemic stroke in older adults - a systematic review.
Meinshausen M; Rieckert A; Renom-Guiteras A; Kröger M; Sommerauer C; Kunnamo I; Martinez YV; Esmail A; Sönnichsen A
BMC Geriatr; 2017 Oct; 17(Suppl 1):225. PubMed ID: 29047342
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet therapy and anticoagulation in patients with hypertension.
Griffin G
Am Fam Physician; 2005 Mar; 71(5):897-9. PubMed ID: 15768617
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet agents and anticoagulants for hypertension.
Lip GY; Felmeden DC
Cochrane Database Syst Rev; 2004; (3):CD003186. PubMed ID: 15266473
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of dipeptidyl peptidase 4 inhibitors in the management of type 2 diabetes in older adults: a systematic review and development of recommendations to reduce inappropriate prescribing.
Schott G; Martinez YV; Ediriweera de Silva RE; Renom-Guiteras A; Vögele A; Reeves D; Kunnamo I; Marttila-Vaara M; Sönnichsen A
BMC Geriatr; 2017 Oct; 17(Suppl 1):226. PubMed ID: 29047372
[TBL] [Abstract][Full Text] [Related]
5. Thiazides in the management of hypertension in older adults - a systematic review.
Sommerauer C; Kaushik N; Woodham A; Renom-Guiteras A; Martinez YV; Reeves D; Kunnamo I; Al Qur An T; Hübner S; Sönnichsen A
BMC Geriatr; 2017 Oct; 17(Suppl 1):228. PubMed ID: 29047359
[TBL] [Abstract][Full Text] [Related]
6. Critical appraisal of network meta-analyses evaluating the efficacy and safety of new oral anticoagulants in atrial fibrillation stroke prevention trials.
Cope S; Clemens A; Hammès F; Noack H; Jansen JP
Value Health; 2015 Mar; 18(2):234-49. PubMed ID: 25773559
[TBL] [Abstract][Full Text] [Related]
7. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.
Segal JB; McNamara RL; Miller MR; Powe NR; Goodman SN; Robinson KA; Bass EB
Cochrane Database Syst Rev; 2001; (1):CD001938. PubMed ID: 11279741
[TBL] [Abstract][Full Text] [Related]
9. Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk.
Nishtala PS; Castelino RL; Peterson GM; Hannan PJ; Salahudeen MS
J Clin Pharm Ther; 2016 Jun; 41(3):279-84. PubMed ID: 27062272
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack.
Saxena R; Koudstaal P
Cochrane Database Syst Rev; 2004 Oct; (4):CD000187. PubMed ID: 15494992
[TBL] [Abstract][Full Text] [Related]
11. Valvular-CHADS-VASc as a safer alternative to CHADS-VASc score.
Chatzimavridou-Grigoriadou V; Kanavidis P; Mathioudakis AG
Int J Cardiol; 2016 Oct; 221():1051-2. PubMed ID: 27447814
[No Abstract] [Full Text] [Related]
12. Role of Antiplatelet Therapy in Stroke Prevention in Patients With Atrial Fibrillation.
Manaktala R; Kluger J
J Am Osteopath Assoc; 2017 Dec; 117(12):761-771. PubMed ID: 29181519
[TBL] [Abstract][Full Text] [Related]
13. The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation.
Golive A; May HT; Bair TL; Jacobs V; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
Am J Cardiol; 2017 Jul; 120(1):75-82. PubMed ID: 28483209
[TBL] [Abstract][Full Text] [Related]
14. Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269].
Mant JW; Richards SH; Hobbs FD; Fitzmaurice D; Lip GY; Murray E; Banting M; Fletcher K; Rahman J; Allan T; Raftery J; Bryan S;
BMC Cardiovasc Disord; 2003 Aug; 3():9. PubMed ID: 12939169
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.
Aronow WS
Drugs Aging; 1999 Aug; 15(2):91-101. PubMed ID: 10495069
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks.
Koudstaal PJ
Cochrane Database Syst Rev; 2000; (2):CD000187. PubMed ID: 10796315
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?
Duerschmied D; Brachmann J; Darius H; Frey N; Katus HA; Rottbauer W; Schäfer A; Thiele H; Bode C; Zeymer U
Clin Res Cardiol; 2018 Jul; 107(7):533-538. PubMed ID: 29679144
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
